Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy
- R. Cimaz
- A. Romeo
- A. Scarano
- T. Avcin
- M. Viri
- P. Veggiotti
- A. Gatti
- M. Lodi
- L. Catelli
- P. Panzeri
- G. Cecchini
- P. L. Meroni
DOIAbstract
To measure anti-cardiolipin (aCL), anti-beta2 glycoprotein I (anti-beta2GPI), and anti-prothrombin (aPT) antibodies in young patients with epilepsy, and to correlate their presence with demographic data, clinical diagnoses, laboratory and neuroradiologic findings, and antiepileptic drugs (AEDs)
Add to ORKG